Dr. Davin K. Quinn, MD

Dr. Quinn practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Quinn's NPI, 1174659593, was assigned on February 27, 2007. Dr. Quinn graduated from Harvard Medical School in 2004. Dr. Quinn holds New Mexico license MD2009-0422.

Dr. Quinn's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Quinn's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Quinn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quinn practices, 2 sites in all. Vendor and product names are available with a free account.

Psychosomatic medicine is Dr. Quinn's primary specialty in the NPI Registry, under taxonomy code 2084P0015X. Dr. Quinn is board certified in brain injury medicine by the American Board of Emergency Medicine. Dr. Quinn is licensed in New Mexico.

CMS data shows 27 Medicare services from Dr. Quinn across 1 procedure code in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $1,955 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Quinn in 2024. The largest group is under 65, with 22 patients. 70% of them have mood disorders, and 68% have depression. 46% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Quinn's median patient age at 46, with 38% women.

In 2024, Dr. Quinn wrote 1,443 Medicare Part D claims for 87 patients. 97% of them were for generic drugs. CMS names the drug for 1,286 of them, across 37 drugs with 11 or more claims each, at $56,145 in total drug cost. In 2023, CMS named 1,117 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Quinn for performance year 2024, reported as part of a group. Dr. Quinn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quinn as offering telehealth.

Dmand AI links 69 papers to Dr. Quinn, published from 2012 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Brain, Electroencephalography and Electroconvulsive Therapy. Dr. Quinn has published most often in Psychosomatics. Dr. Quinn's most frequent co-authors are Christopher C. Abbott, MD, Jacqueline H. Story-Remer and Durga Roy.

Dmand AI links Dr. Quinn to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Brain Concussion, Depressive Disorder, Treatment-Resistant and Post-Concussion Syndrome. University of New Mexico sponsors the most, 2.

CMS Open Payments shows 7 general payments to Dr. Quinn from 2 drug and device companies from 2019 to 2024. Travel and lodging make up the largest share, 85% of the total. LivaNova USA, Inc. paid the most, $1,324.

Dr. Quinn graduated from Harvard Medical School in 2004.